The pharma stock rose from Rs 291 on August 14 to Rs 435 recorded on February 15, which translates into an upside of about 50% in six months. It rose more than 6% in a week and over 20% in the last 3 months. The momentum helped the stock to break out from a month-long consolidation.
Polycab price surged 3.18%, and open interest saw an increase of 0.46%. Grasim Industries stock rose 3.01%, and the open interest saw an increase of 0.45%.